Protagonist Therapeutics Inc Revenue per Employee (PTGX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Protagonist Therapeutics inc   (NASDAQ: PTGX)
 

Protagonist Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5723.64% in the third quarter 2026, year on year to cumulative value of $552 million, Protagonist Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 4,179,470, this is below the company average.
Within the Healthcare sector Employees of 152 other companies have achieved higher revenue per employee. While Protagonist Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 775 to 1468. Protagonist Therapeutics Inc has 132 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTGX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 5723.64 % 3749.17 % 99.03 % -95.64 % 0.79 %
Sales per Employee (TTM) $ 4,179,470 2,136,303 561,083 348,606 1,584,977
PTGX's Total Ranking # 1468 # 775 # 370 # 261 #
Seq. Revenue Change 28.54 % 278.72 % 657.94 % 57.83 % -15.04 %

PTGX Company Profile >> Back to PTGX Efficiency Comparisons >> Compare PTGX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 97
Healthcare Sector # 153
Overall Market # 1468

Revenue per Employee Statistics
High Average Low
$ 3,291,159 $ 666,178 $ -1,023
(Dec 31 2024)   (Sep 30 2019)



Financial Statements
Protagonist Therapeutics Inc 's Revenue MRQ $ 274 Millions Visit PTGX's Income Statement
Protagonist Therapeutics Inc 's Revenues TTM $ 552 Millions Visit PTGX's aggregate revenue growth
What are PTGX's Sales? Visit PTGX's Sales by Segment




Other Ratios
Protagonist Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PTGX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PTGX's Competitors
Revenue per Employee for PTGX's Suppliers
Revenue per Employee for PTGX's Customers

You may also want to know
PTGX's Sales Growth Rates PTGX's Pe Price to earnings ratio PTGX's Receivables Turnover Ratio PTGX's Stock Quote
PTGX's Net Income Growth Rates PTGX's Ps Price to Sales ratio PTGX's Sales per Employee PTGX's Asset Turnover Ratio
PTGX's Net Margin PTGX's Pb Price to Book ratio PTGX's Financial Strength Ratios PTGX's Dividend Payout Ratio
Date modified: 2026-11-07T10:14:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Ligand Pharmaceuticals Incorporated  5,400,574.47 $ 253.827  Million 47 
Community Health Systems Inc   3,759,032.26 $ 11,653.000  Million 3,100 
Illumina Inc   3,545,312.50 $ 4,538.000  Million 1,280 
Kiniksa Pharmaceuticals International Plc  2,584,598.36 $ 945.963  Million 366 
Aurinia Pharmaceuticals Inc   2,513,578.12 $ 321.738  Million 128 
Zevra Therapeutics Inc   2,304,065.57 $ 140.548  Million 61 
Nurix Therapeutics Inc   2,214,309.15 $ 701.936  Million 317 
Exelixis Inc   2,176,862.25 $ 2,496.861  Million 1,147 
Incyte Corporation  2,113,485.94 $ 6,010.754  Million 2,844 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.